Skip to main content

Bowel Cleansing

0
Pipeline Programs
2
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Ipsen
IpsenChina - Tianjin
2 programs
Eziclen®/Izinova®N/A1 trial
EziclenPHASE_31 trial
Active Trials
NCT02630680Completed1,286Est. Apr 2017
NCT02321462Completed296Est. Dec 2015
Ferring Pharmaceuticals
Ferring PharmaceuticalsArgentina - Buenos Aires
2 programs
Sodium Picosulfate, Magnesium Oxide and Citric AcidN/A1 trial
PICOPREPPHASE_31 trial
Active Trials
NCT03631446Completed1,298Est. Dec 2021
NCT02239692Completed204Est. Jun 2015

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
IpsenEziclen
Ferring PharmaceuticalsPICOPREP
Ferring PharmaceuticalsSodium Picosulfate, Magnesium Oxide and Citric Acid
IpsenEziclen®/Izinova®

Clinical Trials (4)

Total enrollment: 3,084 patients across 4 trials

NCT02321462IpsenEziclen

Efficacy, Safety and Tolerability of Eziclen in Adult Subjects Undergoing Colonoscopy

Start: Mar 2015Est. completion: Dec 2015296 patients
Phase 3Completed
NCT02239692Ferring PharmaceuticalsPICOPREP

A Trial Comparing the PICOPREP Tailored Dosing Schedule to the PICOPREP Day-before Dosing Schedule for Colon Cleansing in Preparation for Colonoscopy

Start: Nov 2014Est. completion: Jun 2015204 patients
Phase 3Completed
NCT03631446Ferring PharmaceuticalsSodium Picosulfate, Magnesium Oxide and Citric Acid

Drug Use-Results Survey on Picoprep® Combination Powder

Start: Aug 2017Est. completion: Dec 20211,298 patients
N/ACompleted
NCT02630680IpsenEziclen®/Izinova®

Eziclen Drug Utilisation in Real Life Setting

Start: Oct 2015Est. completion: Apr 20171,286 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.